发明授权
- 专利标题： Fused pyrazoles as FGFR inhibitors
- 专利标题（中）： 融合吡唑作为FGFR抑制剂
-
申请号： US14132653申请日： 2013-12-18
-
公开(公告)号： US09266892B2公开(公告)日： 2016-02-23
- 发明人: Jincong Zhuo , Meizhong Xu , Ding-Quan Qian
- 申请人： Incyte Corporation , Incyte Holdings Corporation
- 申请人地址： US DE Wilmington US DE Wilmington
- 专利权人： Incyte Holdings Corporation,Incyte Corporation
- 当前专利权人： Incyte Holdings Corporation,Incyte Corporation
- 当前专利权人地址： US DE Wilmington US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： A61K31/498
- IPC分类号： A61K31/498 ; C07D487/04 ; C07D471/04 ; A61K31/519 ; A61K31/5025 ; A61K31/437
摘要：
The present invention relates to fused pyrazole derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
公开/授权文献
- US20140171405A1 Fused Pyrazoles as FGFR Inhibitors 公开/授权日：2014-06-19
信息查询
IPC分类:
